Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

Maria T Abreu

Showing results (101-110 of 219) with videos related to

Pageof 22
Sort By:
Journal of Immunology (Baltimore, Md. : 1950)|October 21, 2004
Beta-defensin-2 expression is regulated by TLR signaling in intestinal epithelial cellsPuja Vora, Adrienne Youdim, Lisa S Thomas, et al.
The Journal of Experimental Medicine|January 8, 2014
Pro-inflammatory human Th17 cells selectively express P-glycoprotein and are refractory to glucocorticoidsRadha Ramesh, Lina Kozhaya, Kelly McKevitt, et al.
BMC Gastroenterology|July 20, 2010
The role of prostaglandin E2 (PGE 2) in toll-like receptor 4 (TLR4)-mediated colitis-associated neoplasiaYasmin Hernandez, John Sotolongo, Keith Breglio, et al.
Journal of Crohn'S & Colitis|June 13, 2024
Early and Sustained Symptom Control with Mirikizumab in Patients with Ulcerative Colitis in the Phase 3 LUCENT ProgrammeSilvio Danese, Axel Dignass, Katsuyoshi Matsuoka, et al.
Crohn'S & Colitis 360|February 13, 2023
Patient Adherence to Fecal Calprotectin Testing Is Low Compared to Other Commonly Ordered Tests in Patients With Inflammatory Bowel DiseaseNidah S Khakoo, Ayanna Lewis, Giovanni A Roldan, et al.
Gastroenterology|June 5, 2008
Toll-like receptor signaling in small intestinal epithelium promotes B-cell recruitment and IgA production in lamina propriaLimin Shang, Masayuki Fukata, Nanthakumar Thirunarayanan, et al.
Clinical Gastroenterology and Hepatology : the Official Clinical Practice Journal of the American Gastroenterological Association|January 9, 2021
Patients With Low Drug Levels or Antibodies to a Prior Anti-Tumor Necrosis Factor Are More Likely to Develop Antibodies to a Subsequent Anti-Tumor Necrosis FactorNiels Vande Casteele, Maria T Abreu, Sarah Flier, et al.
Gut|February 12, 2015
The association of tissue anti-TNF drug levels with serological and endoscopic disease activity in inflammatory bowel disease: the ATLAS studyAndres J Yarur, Anjali Jain, Daniel A Sussman, et al.
Journal of Gastroenterology|July 25, 2023
Correlation of mucosal healing endpoints with long-term clinical and patient-reported outcomes in ulcerative colitisGareth Parkes, Ryan C Ungaro, Silvio Danese, et al.
Inflammatory Bowel Diseases|October 29, 2005
Design issues and outcomes in IBD clinical trialsBruce E Sands, Maria T Abreu, George D Ferry, et al.
Pageof 22

Showing results (101-110 of 219) with videos related to

Sort By:
Pageof 22
Journal of Immunology (Baltimore, Md. : 1950)|October 21, 2004
Beta-defensin-2 expression is regulated by TLR signaling in intestinal epithelial cellsPuja Vora, Adrienne Youdim, Lisa S Thomas, et al.
The Journal of Experimental Medicine|January 8, 2014
Pro-inflammatory human Th17 cells selectively express P-glycoprotein and are refractory to glucocorticoidsRadha Ramesh, Lina Kozhaya, Kelly McKevitt, et al.
BMC Gastroenterology|July 20, 2010
The role of prostaglandin E2 (PGE 2) in toll-like receptor 4 (TLR4)-mediated colitis-associated neoplasiaYasmin Hernandez, John Sotolongo, Keith Breglio, et al.
Journal of Crohn'S & Colitis|June 13, 2024
Early and Sustained Symptom Control with Mirikizumab in Patients with Ulcerative Colitis in the Phase 3 LUCENT ProgrammeSilvio Danese, Axel Dignass, Katsuyoshi Matsuoka, et al.
Crohn'S & Colitis 360|February 13, 2023
Patient Adherence to Fecal Calprotectin Testing Is Low Compared to Other Commonly Ordered Tests in Patients With Inflammatory Bowel DiseaseNidah S Khakoo, Ayanna Lewis, Giovanni A Roldan, et al.
Gastroenterology|June 5, 2008
Toll-like receptor signaling in small intestinal epithelium promotes B-cell recruitment and IgA production in lamina propriaLimin Shang, Masayuki Fukata, Nanthakumar Thirunarayanan, et al.
Clinical Gastroenterology and Hepatology : the Official Clinical Practice Journal of the American Gastroenterological Association|January 9, 2021
Patients With Low Drug Levels or Antibodies to a Prior Anti-Tumor Necrosis Factor Are More Likely to Develop Antibodies to a Subsequent Anti-Tumor Necrosis FactorNiels Vande Casteele, Maria T Abreu, Sarah Flier, et al.
Gut|February 12, 2015
The association of tissue anti-TNF drug levels with serological and endoscopic disease activity in inflammatory bowel disease: the ATLAS studyAndres J Yarur, Anjali Jain, Daniel A Sussman, et al.
Journal of Gastroenterology|July 25, 2023
Correlation of mucosal healing endpoints with long-term clinical and patient-reported outcomes in ulcerative colitisGareth Parkes, Ryan C Ungaro, Silvio Danese, et al.
Inflammatory Bowel Diseases|October 29, 2005
Design issues and outcomes in IBD clinical trialsBruce E Sands, Maria T Abreu, George D Ferry, et al.
Pageof 22